1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1) : final survival analysis of a randomised, controlled, phase 3 trial
(
- Contribution to journal › Article
- 2020
-
Mark
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
(
- Contribution to journal › Article
-
Mark
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial
(
- Contribution to journal › Article
- 2018
-
Mark
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
(
- Contribution to journal › Article